{"id":69362,"date":"2025-07-14T12:54:11","date_gmt":"2025-07-14T15:54:11","guid":{"rendered":"https:\/\/insurancecorp.com.br\/pt\/?p=69362"},"modified":"2025-07-14T12:54:11","modified_gmt":"2025-07-14T15:54:11","slug":"ans-promove-audiencia-publica-57","status":"publish","type":"post","link":"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/","title":{"rendered":"ANS promove Audi\u00eancia P\u00fablica 57"},"content":{"rendered":"<p class=\"v1paragraph\">A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 18\/7, a\u00a0<a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-no-57\" target=\"_blank\" rel=\"noopener noreferrer\">Audi\u00eancia P\u00fablica 57<\/a> para debater as propostas de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias:<\/p>\n<p class=\"v1paragraph\">&#8211; Fremanezumabe, medicamento para tratamento preventivo de enxaqueca em adultos com pelo menos quatro dias de enxaqueca por m\u00eas, refrat\u00e1rios a tr\u00eas tratamentos pr\u00e9vios; e<\/p>\n<p class=\"v1paragraph\">&#8211; Belimumabe, medicamento para tratamento adjuvante de pacientes adultos (com idade igual ou superior a 18 anos) com l\u00fapus eritematoso sist\u00eamico (LES) e alto grau de atividade da doen\u00e7a apesar do uso da terapia padr\u00e3o.<\/p>\n<p class=\"v1paragraph\">As propostas tiveram recomenda\u00e7\u00e3o preliminar de n\u00e3o incorpora\u00e7\u00e3o \u00e0 lista de coberturas obrigat\u00f3rias pelos planos de sa\u00fade, tendo sido debatidas em reuni\u00f5es t\u00e9cnicas da Comiss\u00e3o de Atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade?(Cosa\u00fade). Elas tamb\u00e9m foram discutidas durante a 9\u00aa Reuni\u00e3o Extraordin\u00e1rio da Diretoria Colegiada (DICOL) de 2025, ocorrida no dia 4\/7, na qual foi aprovada a realiza\u00e7\u00e3o da audi\u00eancia p\u00fablica.<\/p>\n<p class=\"v1paragraph\"><span class=\"v1normaltextrun\">As tecnologias tamb\u00e9m est\u00e3o recebendo contribui\u00e7\u00f5es atrav\u00e9s da Consulta P\u00fablica 158 at\u00e9 29\/7.\u00a0<\/span><span class=\"v1normaltextrun\"><a href=\"https:\/\/www.gov.br\/ans\/pt-br\/assuntos\/noticias\/sociedade\/consulta-publica-158-ans-recebe-contribuicoes-para-atualizacao-do-rol\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui<\/a>\u00a0<\/span><span class=\"v1normaltextrun\">para saber mais.<\/span><\/p>\n<p class=\"v1paragraph\">O evento vai ocorrer de forma remota, pela plataforma Teams, com transmiss\u00e3o pelo YouTube, das 9h30 \u00e0s 12h30.<\/p>\n<p class=\"v1paragraph\">Para participar da\u00a0<a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-no-57\" target=\"_blank\" rel=\"noopener noreferrer\">Audi\u00eancia P\u00fablica 57<\/a>, \u00e9 preciso fazer inscri\u00e7\u00e3o at\u00e9 as 17h do dia 17\/7,\u00a0<a href=\"https:\/\/www.ans.gov.br\/sisge\/cadastro\/default_sisge.asp?id=737\" target=\"_blank\" rel=\"noopener noreferrer\">clicando aqui<\/a>. A grava\u00e7\u00e3o ficar\u00e1 dispon\u00edvel no site da Ag\u00eancia.<\/p>\n<p class=\"v1paragraph\"><a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-no-57\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui<\/a> para conferir todos os documentos referentes a esta audi\u00eancia p\u00fablica, ou acesse o Portal da ANS e, no menu Acesso \u00e0 Informa\u00e7\u00e3o, entre na se\u00e7\u00e3o Participa\u00e7\u00e3o da Sociedade, item Audi\u00eancias P\u00fablicas.<\/p>\n<p><strong>Assessoria de Imprensa ANS<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 18\/7, a\u00a0Audi\u00eancia P\u00fablica 57 para debater as propostas de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias: &#8211; Fremanezumabe, medicamento para tratamento preventivo de enxaqueca em adultos com pelo menos quatro dias de enxaqueca por m\u00eas, refrat\u00e1rios a tr\u00eas tratamentos pr\u00e9vios; [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[380],"tags":[14677,779,8131,3509,5968],"jetpack_featured_media_url":"","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v14.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANS promove Audi\u00eancia P\u00fablica 57 | Revista Insurance Corp | PT-BR<\/title>\n<meta name=\"robots\" content=\"index, follow\" \/>\n<meta name=\"googlebot\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta name=\"bingbot\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS promove Audi\u00eancia P\u00fablica 57 | Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 18\/7, a\u00a0Audi\u00eancia P\u00fablica 57 para debater as propostas de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias: &#8211; Fremanezumabe, medicamento para tratamento preventivo de enxaqueca em adultos com pelo menos quatro dias de enxaqueca por m\u00eas, refrat\u00e1rios a tr\u00eas tratamentos pr\u00e9vios; [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-14T15:54:11+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\",\"name\":\"Revista Insurance Corp\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#logo\",\"inLanguage\":\"pt-BR\",\"url\":\"\",\"caption\":\"Revista Insurance Corp\"},\"image\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#website\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/\",\"name\":\"Revista Insurance Corp | PT-BR\",\"description\":\"A \\u00fanica revista bil\\u00edngue voltada ao mercado de seguro.\",\"publisher\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/insurancecorp.com.br\/pt\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/#webpage\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/\",\"name\":\"ANS promove Audi\\u00eancia P\\u00fablica 57 | Revista Insurance Corp | PT-BR\",\"isPartOf\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#website\"},\"datePublished\":\"2025-07-14T15:54:11+00:00\",\"dateModified\":\"2025-07-14T15:54:11+00:00\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/\"]}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/#webpage\"},\"author\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af\"},\"headline\":\"ANS promove Audi\\u00eancia P\\u00fablica 57\",\"datePublished\":\"2025-07-14T15:54:11+00:00\",\"dateModified\":\"2025-07-14T15:54:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/#webpage\"},\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\"},\"keywords\":\"57,ans,audi\\u00eancia,promove,publica\",\"articleSection\":\"ANS\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/insurancecorp.com.br\/pt\/2025\/07\/14\/ans-promove-audiencia-publica-57\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af\",\"name\":\"Publica\\u00e7\\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#personlogo\",\"inLanguage\":\"pt-BR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/17226f1f60486eb25d4c6b301ffed37f?s=96&d=mm&r=g\",\"caption\":\"Publica\\u00e7\\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/69362"}],"collection":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/comments?post=69362"}],"version-history":[{"count":1,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/69362\/revisions"}],"predecessor-version":[{"id":69363,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/69362\/revisions\/69363"}],"wp:attachment":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media?parent=69362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/categories?post=69362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/tags?post=69362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}